-
Successful treatment of respiratory failure in Hirayama disease
Sol, N., Hartman, J., ten Kate, M., van Kempen, Z., van der Kooi, A., Vandertop, P., Tuinman, P-R. & van Oosten, B., 1 Feb 2024, In: American Journal of Emergency Medicine. 76, p. 272.e3-272.e5Research output: Contribution to journal › Article › Academic › peer-review
-
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)
Toorop, A. A., van Lierop, Z. Y., Gelissen, L. M., Hoitsma, E., Zeinstra, E. M., van Rooij, L. C., van Munster, C. E., Vennegoor, A., Mostert, J. P., Wokke, B. H., Kalkers, N. F., Hoogervorst, E. L., van Eijk, J. J., Roosendaal, C. M., Kragt, J. J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L., Kloosterziel, M. E., & 16 others , 14 Nov 2023, (E-pub ahead of print) In: Journal of neurology, neurosurgery, and psychiatry.Research output: Contribution to journal › Article › Academic
-
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
Dutch GBS Study Group, 1 Apr 2021, In: Lancet neurology. 20, 4, p. 275-283 9 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications